Breaking News

Tweet TWEET

ABB, Meyer Burger, Novartis, Roche Holding: Swiss Equity Market Preview

The following is a list of companies whose shares may have unusual price changes in Zurich. Stock symbols are in parentheses and share prices are from the last close.

The Swiss Market Index of the biggest and most actively traded companies rose 0.8 percent to 6,418.82. The broader Swiss Performance Index increased 0.9 percent to 5,637.74.

ABB Ltd. (ABBN VX): The company agreed to buy Louisiana- based K-TEK for an undisclosed sum. K-TEK, which will join the measurement products business unit within ABB’s process automation division, has annual sales of about $50 million and employs more than 250 people with operations in China, the Netherlands, India and South Africa in addition to the U.S., according to an e-mailed statement. The shares rose 0.7 percent to 19.83 francs.

APEN AG (APEN SW): Christian Wenger has revoked his intention to step down from Apen Ltd.’s board and will stand for re-election at the June 7 annual shareholders meeting, the Swiss investment company said in an e-mailed statement. The shares lost 0.9 percent to 16.75 francs.

Meyer Burger Technology AG (MBTN SW): The maker of industrial cutting equipment won an order worth more than 25 million Swiss francs ($21.7 million) with a new customer in China. The shares gained 1 percent to 25.3 francs.

Mindset Holding AG (MIND SW): The electric sports car designer will increase its capital by selling 200,000 shares. Mindset dropped 2.7 percent to 3.6 francs.

Novartis AG (NOVN VX): The drugmaker’s Tasigna medicine was more effective at treating newly diagnosed leukemia than the company’s best-selling Gleevec drug.

Tasigna cut levels of a protein linked to chronic myeloid leukemia in three times as many patients as in those taking Gleevec after 18 months, the Basel, Switzerland-based company said today. The shares rose 1 percent to 53.35 francs.

Partners Group Holding AG (PGHN SW): The Swiss money manager which is focused on private equity investments had its price estimate lifted to 147 francs from 121 francs at Credit Suisse Group AG. The brokerage kept a “neutral” rating. The shares ended unchanged at 133.7 francs.

Roche Holding AG (ROG VX): UBS AG added the world’s biggest maker of cancer medicines to its “most preferred” stocks in the European pharmaceutical industry. The shares advanced 1.1 percent to 164.7 francs.

To contact the reporter on this story: Francesca Cinelli in Milan at fcinelli@bloomberg.net.

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.